ArticleBMC oral health2026
Water-soluble yeast β-glucan accelerates oral ulcer healing in rats via collagen synthesis and epithelial regeneration.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundOral ulcer is a common, painful lesion that heals slowly and easily becomes secondary-infected. β-glucan, a well-known immunomodulator, has shown potential in promoting wound repair. However, the therapeutic efficacy of its water-soluble form on oral mucosal wounds remains insufficiently studied. Therefore, this study aimed to evaluate the effects of water-soluble yeast β-glucan on the healing of oral ulcers in a rat model.
methodsForty rats were randomly assigned to five groups (n = 8): (1) negative control (2), standard care control (0.12% chlorhexidine), and (3–5) experimental groups treated with 0.1%, 0.5%, or 1.0% water-soluble yeast β-glucan, respectively. Oral ulcers were chemically induced, and lesion size and clinical status were monitored daily. Histopathological changes were assessed by hematoxylin–eosin, Masson trichrome, and immunohistochemical staining. Data were analyzed by one-way analysis of variance using GraphPad Prism 10.0; P < 0.05 was considered statistically significant.
resultsOn day 6, water-soluble yeast β-glucan- and chlorhexidine-treated rats exhibited significantly smaller ulcer areas, faster healing rates, complete epithelialization, and improved histological scores compared with the negative controls (P < 0.05). Water-soluble yeast β-glucan treatment also increased collagen deposition (P < 0.05). Moreover, water-soluble yeast β-glucan-treated animals showed significantly greater weight gain than the negative controls (P < 0.0001).
conclusionsThis study establishes the beneficial effect of water-soluble yeast β-glucan on oral mucosal repair and provides a clear rationale for its clinical evaluation in human oral ulcers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.